WESPAC Advisors’s CVS Health CVS Stock Holding History

WESPAC Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,063	Closed	-$763K	–	185
2025 Q2	$763K	Buy	+11,063	New	+$725K	0.53%	73
2023 Q1	–	Sell	-2,163	Closed	-$202K	–	112
2022 Q4	$202K	Sell	2,163 -712	-25%	-$68.7K	0.35%	63
2022 Q3	$274K	Buy	+2,875	New	+$285K	0.37%	69
2015 Q3	–	Sell	-12,458	Closed	-$1.31M	–	75
2015 Q2	$1.31M	Sell	12,458 -1,471	-11%	-$150K	0.98%	40
2015 Q1	$1.44M	Sell	13,929 -286	-2%	-$28.9K	1.09%	36
2014 Q4	$1.37M	Buy	14,215 +3,083	+28%	+$272K	0.96%	39
2014 Q3	$886K	Buy	11,132 +3,447	+45%	+$272K	0.71%	59
2014 Q2	$579K	Sell	7,685 -1,392	-15%	-$105K	0.66%	62
2014 Q1	$680K	Buy	+9,077	New	+$641K	0.59%	73
2013 Q3	–	Sell	-3,690	Closed	-$211K	–	113
2013 Q2	$211K	Buy	+3,690	New	+$214K	0.32%	90

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WESPAC Advisors's CVS Position: Q3 2025 in Review

WESPAC Advisors sold out of CVS Health (CVS) in Q3 2025, closing a stake of 11,063 shares — an estimated $763K sold.

WESPAC Advisors first reported a position in CVS in Q2 2013 and held it in 10 quarters. The position peaked at $1.44M in Q1 2015. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

WESPAC Advisors reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
WESPAC Advisors sold 11,063 CVS Health shares in Q3 2025, an estimated $763K.
WESPAC Advisors first reported a position in CVS Health in Q2 2013 and held it in 10 quarters.
WESPAC Advisors's CVS Health position peaked at $1.44M in Q1 2015.
1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on WESPAC Advisors's 13F filing for Q3 2025, filed 27 Oct 2025.